查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1871027

生物成像试剂市场按产品类型、技术、应用和最终用户划分－2025-2032年全球预测

Biological Imaging Reagent Market by Product Type, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，生物成像试剂市场规模将达到 312.1 亿美元，复合年增长率为 7.41%。

关键市场统计数据
基准年 2024 176.1亿美元
预计年份：2025年 189.4亿美元
预测年份 2032 312.1亿美元
复合年增长率 (%) 7.41%

了解生物成像试剂在现代研究和诊断中的战略重要性，以及它们如何促进可重复性和转化性进展。

生物成像试剂透过实现分子、细胞和组织层级的生物系统视觉化、定量和解读，为现代生命科学工作流程提供支援。近年来，试剂设计、偶联化学以及与高内涵成像平台相容性的进步，拓展了这些试剂在基础研究、转化研究、诊断和工业筛检等领域的应用。随着研究人员对具有更高特异性、更优信噪比以及能够与多重分析和自动化平台无缝整合的试剂的需求不断增长，供应商也积极响应，提供特性更完善、应用更优化的产品。

从多重空间生物学到仪器主导的品质要求和数位化集成，重大的技术和市场变革正在重塑生物成像试剂。

生物成像试剂领域正经历着一场变革性的转变，其驱动力来自于技术创新和不断变化的客户需求。首先，多重成像和单细胞空间生物学的兴起，加速了对能够提供正交读数、交叉反应性最小且光物理性质可预测的试剂的需求。製造商正积极响应这项需求，开发亮度更高、光稳定性更强的染料，并提供预先检验的试剂盒，以缩短复杂检测中的积分时间。

2025年累积关税压力如何促使企业重新调整筹资策略、考虑近岸外包以及采取策略性供应链弹性措施

关税的引入和加强可能会对成像试剂的采购趋势和供应商策略产生重大影响。到2025年，影响特定试剂类别和进口原材料的累积关税将迫使各机构重新评估供应商多元化、库存策略和总到岸成本的计算。事实上，关税提高了某些进口抗体、染料和特殊生化成分的相对成本，从而增加了采购的复杂性，同时也提升了近岸外包和区域製造伙伴关係的吸引力。

按产品类型、技术、应用和最终用户进行详细细分，可以发现产品开发和商业化的目标机会。

细分市场分析揭示了不同产品类型、技术、应用和最终用户的需求驱动因素和技术要求各不相同，从而指明了供应商应优先考虑创新和服务改进的领域。在各类产品中，抗体、酵素、萤光染料、探针和染色剂的需求模式也各不相同。一级抗体和二级抗体有不同的检验和标记需求，而激酶和蛋白酶等酵素则需要稳定性优化的配方和储存条件以维持活性。萤光染料分为有机染料和量子点，二者在亮度、光稳定性和光谱特性方面各有优劣。探针分为DNA探针和RNA探针，其性能取决于杂合反应速度和标记化学方法。染色剂，包括革兰氏染色和苏木精-伊红染色，在组织学中仍然至关重要，因为组织学需要一致的比色结果。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 近红外线萤光探针在临床前研究中用于深层组织成像的应用日益增多
  • 开发多重成像试剂，实现单细胞分析中多种生物标记的同步视觉化
  • 透过整合超高解析度显微镜染料和机器学习实现高通量细胞表型分析
  • 对能够实现体内细胞动态长期追踪的生物相容性量子点成像剂的需求日益增长。
  • 类器官特异性成像试剂能够对用于药物筛检的三维组织模型进行即时监测。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 生物成像试剂市场（依产品类型划分）

  • 抗体
    • 一抗
    • 二抗
  • 酵素
    • 激酶
    • 蛋白酶
  • 萤光染料
    • 有机染料
    • 量子点
  • 探测
    • DNA探针
    • RNA探针
  • 染色
    • 革兰氏染色
    • 苏木精-伊红染色

9. 按技术分類的生物成像试剂市场

  • 生物发光试剂
    • ATP测定
    • 萤光素酶基材
  • 化学冷光试剂
    • ECL 套件
    • HRP基材
  • 比色法
    • Bradford蛋白测定法
    • ELISA试剂盒
  • 萤光显微镜试剂
    • FISH探针
    • 萤光试剂

第十章 生物成像试剂市场（依应用领域划分）

  • 细胞生物学
    • 细胞凋亡检测
    • 细胞活力检测
  • 药物发现
    • 高通量筛检试剂
    • 筛检试验
  • 分子生物学
    • PCR试剂
    • 西方墨点法试剂
  • 病理
    • FISH探针
    • 免疫组织化学（IHC）试剂

第十一章 生物成像试剂市场（依最终用户划分）

  • 学术研究机构
    • 研究所
    • 大学
  • 医院和诊断实验室
    • 临床实验室
    • 病理实验室
  • 製药和生物技术
    • 大型製药企业
    • 医药外包

第十二章 生物成像试剂市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 生物成像试剂市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国生物成像试剂市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • PerkinElmer, Inc.
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories, Inc.
    • Abcam plc
    • Bruker Corporation
    • Becton Dickinson and Company
    • General Electric Company
Product Code: MRR-1A1A064C059A

The Biological Imaging Reagent Market is projected to grow by USD 31.21 billion at a CAGR of 7.41% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 17.61 billion
Estimated Year [2025] USD 18.94 billion
Forecast Year [2032] USD 31.21 billion
CAGR (%) 7.41%

Framing the strategic importance of biological imaging reagents in modern research and diagnostics and how they enable reproducibility and translational progress

Biological imaging reagents underpin modern life sciences workflows by enabling visualization, quantification, and interpretation of biological systems at molecular, cellular, and tissue scales. Over recent years, advances in reagent design, conjugation chemistries, and compatibility with high-content imaging platforms have broadened the applicability of these reagents across basic research, translational studies, diagnostics, and industrial screening. As investigators demand higher specificity, greater signal-to-noise ratios, and reagents that seamlessly interface with multiplexed and automated platforms, suppliers are responding with more precisely characterized and application-optimized offerings.

The landscape for reagents is shaped not only by scientific innovation but also by practical considerations such as supply chain resilience, cold-chain logistics, and regulatory compliance for clinical applications. Consequently, decision-makers in research institutions, clinical laboratories, and life sciences companies increasingly evaluate reagent choices through a lens that balances technical performance with reproducibility, sourcing risk, and total cost of ownership. Looking ahead, the integration of advanced imaging reagents with computational image analysis, machine learning workflows, and standardized validation protocols will be pivotal in translating laboratory findings into robust, repeatable outcomes in both research and clinical contexts.

Key technological and market shifts reshaping biological imaging reagents, from multiplex spatial biology to instrument-driven quality expectations and digital integration

The biological imaging reagent landscape is experiencing transformative shifts driven by technological innovation and evolving customer expectations. First, the rise of multiplexed imaging and single-cell spatial biology has accelerated demand for reagents that provide orthogonal readouts with minimal cross-reactivity and predictable photophysical properties. Manufacturers are adapting by developing brighter, more photostable dyes, and by offering pre-validated panels that reduce integration time in complex assays.

Second, instrument advances such as super-resolution modalities and high-throughput imaging platforms are raising the bar for reagent specificity and lot-to-lot consistency. Suppliers are consequently investing in improved quality control, lot characterization, and reference standards to assure reproducible performance across diverse imaging systems. Third, digital transformation within laboratories-spanning laboratory information management systems, automated sample handling, and AI-driven image analysis-has increased the value of reagents that are accompanied by comprehensive metadata and validated performance metrics that facilitate downstream computational workflows.

Finally, regulatory and procurement trends are influencing how reagents are sourced and used in clinical and diagnostic applications. As clinical translation accelerates, reagents intended for diagnostics must align with regulatory expectations and quality systems that support clinical validation. Taken together, these shifts are redefining supplier value propositions, placing emphasis on integrated solutions that combine reagent quality, documentation, and interoperability with modern imaging infrastructures.

How cumulative tariff pressures in 2025 prompted rapid procurement recalibration, nearshoring considerations, and strategic supply chain resilience measures

The introduction and escalation of tariff measures can materially affect procurement dynamics and supplier strategies for imaging reagents. In 2025, cumulative tariff actions impacting specific reagent categories and imported raw materials prompted organizations to reassess supplier diversification, inventory strategies, and total landed cost calculations. In practice, tariffs increased procurement complexity by elevating the relative cost of certain imported antibodies, dyes, and specialized biochemical components, while amplifying the appeal of nearshoring and regional manufacturing partnerships.

As a result, many institutional buyers extended lead times and revised purchasing windows to mitigate exposure to price volatility. Manufacturers and distributors responded by shifting portions of their supply chains, negotiating longer-term contracts, and increasing investments in regional distribution centers and cold-chain infrastructure to limit the direct pass-through of tariff-related cost increases to end users. Moreover, tariff-related disruptions encouraged a renewed focus on supplier qualification and multi-sourcing strategies to maintain continuity for critical reagents.

From a strategic standpoint, the tariffs catalyzed conversations about value engineering and formulation changes that preserve performance while lowering input costs. In addition, organizations with advanced procurement capabilities leveraged hedging approaches and aggregated purchasing across consortia to moderate the immediate impact. While tariffs introduced short- to medium-term headwinds, they also accelerated structural adjustments that may lead to more resilient regional supply ecosystems and a diversified procurement profile for high-priority reagents.

How nuanced segmentation across product type, technology, application, and end user reveals targeted opportunities for product development and commercialization

Segmentation insights reveal differentiated demand drivers and technical requirements across product types, technologies, applications, and end users, informing where suppliers can prioritize innovation and service enhancements. Based on product type, demand patterns vary among antibodies, enzymes, fluorescent dyes, probes, and stains; within antibodies, primary and secondary antibodies present distinct validation and conjugation needs, while enzymes such as kinases and proteases require stability-optimized formulations and activity-preserving storage. Fluorescent dyes split into organic dyes and quantum dots, each with trade-offs in brightness, photostability, and spectral properties. Probes divide into DNA and RNA probes where hybridization kinetics and labeling chemistries dictate performance, and stains including Gram stains and hematoxylin and eosin remain essential for histology with expectations of consistent colorimetric response.

Based on technology, reagent requirements differ between bioluminescence reagents, chemiluminescence reagents, colorimetric assays, and fluorescence microscopy reagents; bioluminescence assays including ATP assays and luciferase substrates prioritize low background and high dynamic range, while chemiluminescence offerings such as ECL kits and HRP substrates focus on signal amplification and ease of use. Colorimetric assays like Bradford protein assays and ELISA kits emphasize quantitation and reproducibility, and fluorescence microscopy reagents including FISH probes and immunofluorescence reagents must be optimized for multiplex compatibility and minimal cross-talk. Based on application, the reagent selection and validation intensity shift across cell biology, drug discovery, molecular biology, and pathology; cell biology assays including apoptosis and viability tests demand robust live-cell compatibility, drug discovery workflows such as high-throughput screening rely on assay robustness and automation readiness, molecular biology tools like PCR and Western blot reagents require stringent specificity and batch consistency, and pathology reagents for FISH and IHC necessitate regulatory-grade documentation and reproducible staining protocols. Based on end user, expectations and purchasing behaviors vary among academic and research institutes, hospitals and diagnostic labs, and pharmaceutical and biotechnology organizations; academic settings often prioritize flexibility and breadth, hospitals and clinical laboratories emphasize validated clinical utility and compliance, and pharmaceutical and biotech firms require scalable supply, regulatory traceability, and documentation suitable for regulated studies.

This segmentation framework highlights where suppliers can develop tailored value propositions-whether that means offering clinical-grade validation packages for pathology customers, automation-optimized kits for high-throughput screening, or highly characterized conjugates for advanced microscopy. By aligning product development and commercial approaches to these specific segmentation nuances, organizations can improve customer fit, reduce adoption friction, and accelerate time-to-assay validation across distinct user cohorts.

Regional dynamics and distribution realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape procurement, manufacturing, and technical support strategies

Regional dynamics shape both demand and supply strategies for imaging reagents, with distinct priorities emerging across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a robust mix of academic institutions, biotech activity, and clinical laboratories drives demand for high-performance reagents and integrated service offerings; progressive adoption of automated workflows and venture capital-backed translational initiatives encourages suppliers to provide rapid technical support and scalable supply commitments. Conversely, in Europe, the Middle East & Africa region, regulatory harmonization across certain markets and long-established diagnostic networks influence purchasing decisions that favor certified reagents with clear compliance documentation and validated performance across multi-center studies.

In the Asia-Pacific region, strong manufacturing capabilities coexist with rapidly expanding research and clinical infrastructures, resulting in both high-sensitivity demand and competitive local supply. This environment fosters opportunities for partnerships between international suppliers and regional manufacturers to co-develop formulations tailored for local cold-chain and distribution realities. Across these regions, logistical considerations such as freight reliability, customs procedures, and cold-chain capacity materially affect reagent availability and shelf-life management. Consequently, regional strategies that combine localized warehousing, targeted technical support, and adaptive product formats-such as lyophilized reagents or ambient-stable formulations-can improve market access and customer satisfaction while reducing distribution risk.

Competitive dynamics and vendor capabilities that determine supplier trust, strategic partnerships, and differentiated commercial value in imaging reagents

Company-level dynamics within the biological imaging reagents space are shaped by portfolios that balance core reagent lines with application-specific solutions, quality systems, and service capabilities. Leading suppliers that maintain rigorous quality control frameworks, transparent validation data, and multi-platform compatibility continue to command trust from clinical and industrial customers. At the same time, nimble emerging companies often capture niches by introducing specialized chemistries, novel conjugation approaches, or by optimizing reagents for high-throughput and multiplexed workflows.

Strategic partnerships and acquisitions remain central to expanding capability sets-particularly when a supplier augments bench reagent expertise with imaging instrumentation, software analytics, or distribution networks to create integrated offerings. Distribution partners and value-added resellers play a crucial role in enabling market penetration, especially in geographies where local regulatory knowledge and cold-chain logistics are differentiators. Moreover, vendors that invest in reproducibility initiatives-offering lot-specific performance data, application notes, and cross-platform validation-are increasingly preferred by purchasers who prioritize assay robustness. Finally, service elements such as scientific support, training, and custom conjugation options emerge as important competitive levers that support higher-margin engagements and longer-term customer relationships.

Actionable guidance for suppliers and purchasers to strengthen supply resilience, accelerate adoption, and deliver integrated value in evolving imaging workflows

Industry leaders should pursue a pragmatic set of actions to strengthen market position, reduce supply risk, and capture value as imaging workflows evolve. First, invest in product characterization and transparency by providing standardized performance metrics, lot-level data, and validated protocols that reduce buyer uncertainty and accelerate adoption across diverse imaging platforms. Second, diversify supply chains by establishing regional manufacturing or distribution hubs and by qualifying multiple raw material sources to limit exposure to tariff-induced cost shifts and logistical disruptions.

Third, prioritize reagent formulations and packaging that address real-world laboratory constraints, such as ambient-stable formats, pre-mixed workflows for automation, and formats optimized for multiplexed assays. Fourth, deepen technical service offerings by integrating assay troubleshooting, on-site or virtual training, and collaborative validation projects that demonstrate performance in customer-specific use cases. Fifth, explore strategic collaborations with instrument manufacturers and software providers to develop bundled solutions that simplify implementation and deliver end-to-end value. Finally, align commercial and regulatory pathways early for reagents intended for diagnostic use, investing in documentation, traceability, and quality systems that facilitate clinical validation and adoption. By executing these actions in parallel, organizations can improve resilience, accelerate customer uptake, and build differentiated, defensible positions in a complex and fast-evolving market.

An evidence-driven methodology combining primary stakeholder interviews, technical literature synthesis, and scenario analysis to support robust strategic insights

The methodology underpinning this analysis integrates multi-disciplinary inputs to ensure a rigorous, reproducible assessment of the biological imaging reagents landscape. Primary research included structured interviews with procurement leaders, laboratory directors, and R&D scientists across academic, clinical, and industry settings to capture firsthand perspectives on reagent performance requirements, sourcing constraints, and service expectations. Secondary research involved a systematic review of published literature, technical application notes, regulatory guidance documents, and product specifications to triangulate claims of reagent performance and compatibility with contemporary imaging platforms.

Analytical approaches included qualitative synthesis of thematic insights, cross-segmentation comparison to identify differential demand drivers, and scenario analysis to assess the operational impact of external factors such as tariff changes and supply chain disruptions. Emphasis was placed on reproducibility and documentation: when vendors provided independent validation data, that information was evaluated in the context of typical laboratory workflows and instrument modalities. Limitations of the methodology are transparently acknowledged, including variability in privately held company disclosures and heterogeneity in user-reported performance. Where possible, findings were corroborated across multiple sources to reduce bias and to offer pragmatic, evidence-informed recommendations for stakeholders.

Concluding perspective on the evolving reagent ecosystem and why transparency, resilience, and integration determine long-term value in imaging workflows

In summary, biological imaging reagents remain foundational to contemporary life sciences research, diagnostics, and drug development, and their role is expanding in step with advances in instrumentation and computational analysis. The combined pressures of higher technical expectations, supply chain complexity, and regulatory scrutiny are redefining supplier value propositions toward greater transparency, localized resilience, and integrated service offerings. Moving forward, reagents that are accompanied by rigorous characterization, compatibility documentation, and practical support for automation and multiplexing will gain preference among demanding end users.

Strategic responses to recent tariff developments and geopolitical uncertainties have accelerated nearshoring, multi-sourcing, and investments in regional distribution and cold-chain capabilities. At the same time, technological trends-such as single-cell spatial assays, super-resolution imaging, and AI-enabled image analysis-are elevating performance requirements and creating opportunities for suppliers that can translate novel chemistries and validated workflows into reproducible, scalable solutions. For stakeholders across academia, clinical labs, and industry, the imperative is clear: prioritize reagents and partners that demonstrate not only scientific excellence but also operational reliability and a commitment to enabling reproducible, translational science.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of near-infrared fluorescent probes for deep tissue imaging in preclinical research
  • 5.2. Development of multiplexed imaging reagents for simultaneous visualization of multiple biomarkers in single-cell analysis
  • 5.3. Integration of super-resolution microscopy dyes with machine learning for high-throughput cellular phenotyping
  • 5.4. Growth in demand for biocompatible quantum dot imaging agents for long-term in vivo tracking of cellular dynamics
  • 5.5. Emergence of organoid-specific imaging reagents enabling real-time monitoring of 3D tissue models in drug screening

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Imaging Reagent Market, by Product Type

  • 8.1. Antibodies
    • 8.1.1. Primary Antibodies
    • 8.1.2. Secondary Antibodies
  • 8.2. Enzymes
    • 8.2.1. Kinases
    • 8.2.2. Proteases
  • 8.3. Fluorescent Dyes
    • 8.3.1. Organic Dyes
    • 8.3.2. Quantum Dots
  • 8.4. Probes
    • 8.4.1. DNA Probes
    • 8.4.2. RNA Probes
  • 8.5. Stains
    • 8.5.1. Gram Stains
    • 8.5.2. Hematoxylin And Eosin

9. Biological Imaging Reagent Market, by Technology

  • 9.1. Bioluminescence Reagents
    • 9.1.1. ATP Assays
    • 9.1.2. Luciferase Substrates
  • 9.2. Chemiluminescence Reagents
    • 9.2.1. ECL Kits
    • 9.2.2. HRP Substrates
  • 9.3. Colorimetric Assays
    • 9.3.1. Bradford Protein Assay
    • 9.3.2. Elisa Kits
  • 9.4. Fluorescence Microscopy Reagents
    • 9.4.1. FISH Probes
    • 9.4.2. Immunofluorescence Reagents

10. Biological Imaging Reagent Market, by Application

  • 10.1. Cell Biology
    • 10.1.1. Apoptosis Assays
    • 10.1.2. Cell Viability Assays
  • 10.2. Drug Discovery
    • 10.2.1. High Throughput Screening Reagents
    • 10.2.2. Screening Assays
  • 10.3. Molecular Biology
    • 10.3.1. PCR Reagents
    • 10.3.2. Western Blot Reagents
  • 10.4. Pathology
    • 10.4.1. FISH Probes
    • 10.4.2. IHC Reagents

11. Biological Imaging Reagent Market, by End User

  • 11.1. Academic And Research Institutes
    • 11.1.1. Research Institutes
    • 11.1.2. Universities
  • 11.2. Hospitals And Diagnostic Labs
    • 11.2.1. Clinical Laboratories
    • 11.2.2. Pathology Laboratories
  • 11.3. Pharmaceutical And Biotechnology
    • 11.3.1. Big Pharma
    • 11.3.2. Pharma Outsourcing

12. Biological Imaging Reagent Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Biological Imaging Reagent Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biological Imaging Reagent Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Thermo Fisher Scientific Inc.
    • 15.3.2. Danaher Corporation
    • 15.3.3. Merck KGaA
    • 15.3.4. PerkinElmer, Inc.
    • 15.3.5. Agilent Technologies Inc.
    • 15.3.6. Bio-Rad Laboratories, Inc.
    • 15.3.7. Abcam plc
    • 15.3.8. Bruker Corporation
    • 15.3.9. Becton Dickinson and Company
    • 15.3.10. General Electric Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BIOLOGICAL IMAGING REAGENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BIOLOGICAL IMAGING REAGENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOLOGICAL IMAGING REAGENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRIMARY ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRIMARY ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRIMARY ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRIMARY ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SECONDARY ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SECONDARY ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SECONDARY ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SECONDARY ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY KINASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY KINASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY KINASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY KINASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY KINASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY KINASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROTEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROTEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROTEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROTEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROTEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROTEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ORGANIC DYES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ORGANIC DYES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ORGANIC DYES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ORGANIC DYES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ORGANIC DYES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ORGANIC DYES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY QUANTUM DOTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY QUANTUM DOTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY QUANTUM DOTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY QUANTUM DOTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY QUANTUM DOTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY QUANTUM DOTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DNA PROBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DNA PROBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DNA PROBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DNA PROBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DNA PROBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DNA PROBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RNA PROBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RNA PROBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RNA PROBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RNA PROBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RNA PROBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RNA PROBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY GRAM STAINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY GRAM STAINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY GRAM STAINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY GRAM STAINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY GRAM STAINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY GRAM STAINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HEMATOXYLIN AND EOSIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HEMATOXYLIN AND EOSIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HEMATOXYLIN AND EOSIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HEMATOXYLIN AND EOSIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HEMATOXYLIN AND EOSIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HEMATOXYLIN AND EOSIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ATP ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ATP ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ATP ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ATP ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ATP ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ATP ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY LUCIFERASE SUBSTRATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY LUCIFERASE SUBSTRATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY LUCIFERASE SUBSTRATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY LUCIFERASE SUBSTRATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY LUCIFERASE SUBSTRATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY LUCIFERASE SUBSTRATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ECL KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ECL KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ECL KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ECL KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ECL KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ECL KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HRP SUBSTRATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HRP SUBSTRATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HRP SUBSTRATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HRP SUBSTRATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HRP SUBSTRATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HRP SUBSTRATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BRADFORD PROTEIN ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BRADFORD PROTEIN ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BRADFORD PROTEIN ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BRADFORD PROTEIN ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BRADFORD PROTEIN ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BRADFORD PROTEIN ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ELISA KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ELISA KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ELISA KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ELISA KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ELISA KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IMMUNOFLUORESCENCE REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IMMUNOFLUORESCENCE REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IMMUNOFLUORESCENCE REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IMMUNOFLUORESCENCE REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IMMUNOFLUORESCENCE REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IMMUNOFLUORESCENCE REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APOPTOSIS ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APOPTOSIS ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APOPTOSIS ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APOPTOSIS ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APOPTOSIS ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APOPTOSIS ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL VIABILITY ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL VIABILITY ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL VIABILITY ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL VIABILITY ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL VIABILITY ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL VIABILITY ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HIGH THROUGHPUT SCREENING REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HIGH THROUGHPUT SCREENING REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HIGH THROUGHPUT SCREENING REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HIGH THROUGHPUT SCREENING REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HIGH THROUGHPUT SCREENING REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HIGH THROUGHPUT SCREENING REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SCREENING ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SCREENING ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SCREENING ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SCREENING ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SCREENING ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SCREENING ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PCR REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PCR REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PCR REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PCR REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PCR REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PCR REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY WESTERN BLOT REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY WESTERN BLOT REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY WESTERN BLOT REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY WESTERN BLOT REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY WESTERN BLOT REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY WESTERN BLOT REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IHC REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IHC REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IHC REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IHC REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IHC REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IHC REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL BIOLOGICAL IMAGING RE